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Acute respiratory distress syndrome (ARDS) usually requires symptomatic supportive therapy by intubation and
mechanical ventilation with the supplemental use of high oxygen concentrations. Although oxygen therapy represents
a life-saving measure, the recent discovery of a critical tissue-protecting mechanism predicts that administration of
oxygen to ARDS patients with uncontrolled pulmonary inflammation also may have dangerous side effects.
Oxygenation may weaken the local tissue hypoxia-driven and adenosine A2A receptor (A2AR)-mediated anti-
inflammatory mechanism and thereby further exacerbate lung injury. Here we report experiments with wild-type and
adenosine A2AR-deficient mice that confirm the predicted effects of oxygen. These results also suggest the possibility
of iatrogenic exacerbation of acute lung injury upon oxygen administration due to the oxygenation-associated
elimination of A2AR-mediated lung tissue-protecting pathway. We show that this potential complication of clinically
widely used oxygenation procedures could be completely prevented by intratracheal injection of a selective A2AR
agonist to compensate for the oxygenation-related loss of the lung tissue-protecting endogenous adenosine. The
identification of a major iatrogenic complication of oxygen therapy in conditions of acute lung inflammation attracts
attention to the need for clinical and epidemiological studies of ARDS patients who require oxygen therapy. It is
proposed that oxygen therapy in patients with ARDS and other causes of lung inflammation should be combined with
anti-inflammatory measures, e.g., with inhalative application of A2AR agonists. The reported observations may also
answer the long-standing question as to why the lungs are the most susceptible to inflammatory injury and why lung
failure usually precedes multiple organ failure.
Citation: Thiel M, Chouker A, Ohta A, Jackson E, Caldwell C, et al. (2005) Oxygenation inhibits the physiological tissue-protecting mechanism and thereby exacerbates acute
inflammatory lung injury. PLoS Biol 3(6): e174.
Introduction
Many clinical conditions, including aspiration, trauma, and
hemorrhagic shock, are frequently followed by pulmonary
and systemic infectious and septic complications that lead to
pulmonary dysfunction and subsequent lung failure. Acute
lung injury or its more severe form, the acute respiratory
distress syndrome (ARDS), occur with a frequency of
approximately 130.000 cases and more than 50.000 deaths
from ARDS per year in the United States alone [1]. Intubation
with mechanical ventilation represent one of the most widely
used prophylactic and therapeutic clinical interventions to
counteract the insufficient pulmonary oxygen-delivering
capacity in patients who suffer from severe lung inflamma-
tion. Although the majority of patients respond well to
oxygen therapy, and oxygen toxicity is an uncommon
occurrence in intensive care medicine [2], there remains the
possibility that oxygen therapy may be suboptimal in ARDS
patients, as it may promote deleterious pulmonary inflam-
mation, which fuels this disease process. Since the magnitude
and duration of lung inflammation has been shown to
determine the final outcome of ARDS patients [3], it is
important to carefully evaluate the possible adverse effects of
oxygen on inflammatory processes.
We assumed that lung tissues are protected from overactive
immune cells by the same hypoxia-driven mechanism and
immunosuppressive adenosine A2A receptor (A2AR)-mediated
mechanism that was recently shown to play a critical role in
the down-regulation of inflammation and tissue damage in
different models [4–7]. Accordingly, it is likely that bacterial
toxin-activated immune cells (e.g., granulocytes) cause collat-
eral lung tissue damage with impairment of the local
microcirculation and blood supply, thereby contributing to
the pathogenesis of acute lung injury. The ensuing tissue
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damage-associated hypoxia facilitates the accumulation of
extracellular adenosine [8–12], which then triggers the
activation of immunosuppressive A2ARs on activated immune
cells and causes the accumulation of immunosuppressive
intracellular cyclic adenosine 39,59-monophosphate (cAMP).
This cAMP, in turn, inhibits signaling pathways that are
required for synthesis and secretion of proinflammatory and
cytotoxic mediators by immune cells, and thereby protects
remaining healthy tissues from continuing immune damage.
Since this physiological tissue-protecting mechanism depends
on the hypoxia-produced extracellular adenosine [8–12], and
since the oxygenation of lungs in intubated patients is
performed to increase oxygen tension—with the goal of
abolishing the hypoxia but disrupting the adenosine accu-
mulation—we reasoned that such interruption of the hypoxia
fi adenosinefi A2AR pathway by oxygenation could lead to a
disengagement of the critical tissue-protecting mechanism
and to an unintended exaggeration of inflammatory lung
damage (iatrogenic disease). Thus, oxygenation may eliminate
this lung-protecting pathway and thereby contribute to
pulmonary complications.
We confirm our prediction in several in-vivo models of
lung infection and inflammation and report that oxygenation
does indeed strongly exacerbate inflammatory lung damage
and accelerate death in mice by the interruption of the
hypoxia fi adenosine fi A2AR pathway. We also suggest an
effective and feasible therapeutic countermeasure to prevent
deleterious effects of oxygenation: Exogenously added syn-
thetic A2AR agonist compensated for the loss of endogenously
formed adenosine in inflamed lungs of oxygenated mice, and
thereby prevented inflammatory lung injury and prevented
death.
Results
Exacerbation of Inflammatory Lung Injury and Death in
Oxygenated Mice
To test our prediction, we subjected mice to inhalation of
combined toxins from gram-positive and gram-negative
bacteria. In this model of polymicrobial lung infection,
intratracheal (IT) injection of both lipopolysaccharide (LPS)
and staphylococcal enterotoxin B (SEB) strongly potentiates
their toxicity [13].
The results of these assays confirmed the prediction of
exaggerated lung injury in mice in conditions that mimic
therapeutic oxygenation, and this is reflected in the dramatic
increases in inflammatory lung damage in different in vivo
and ex vivo assays (Figures 1 and 2).
Five times more mice with inflamed lungs died after
exposure to 100% oxygen than those left at 21% ambient
oxygen tension (Figure 1). This was further confirmed by a
much more pronounced increase in the alveolocapillary
permeability and severe overall impairment of lung gas
exchange, as evidenced by the increase in the amount of
protein recovered from the alveolar space by bronchoalveo-
lar lavage (BAL), as well as by the decrease in arterial oxygen
partial pressure (pO2) values of previously oxygen-exposed
mice when returned to normal atmosphere (Figure 2A).
Although exposure of mice to 100% oxygen alone (with no
toxin inhalation) did induce a small accumulation of BAL
fluid protein, the magnitude of that effect could not account
for the dramatic increases in lung vascular permeability and
impairment of lung gas exchange when both toxins and
oxygenation were used (Figure 2A).
The exacerbation of inflammatory lung injury was also
observed when mice were exposed to 60% oxygen, a
concentration considered in human patients to be fairly safe.
Compared to toxin-injected animals breathing 21% oxygen,
those breathing 60% oxygen accumulated much more
exudate proteins in the alveolar spaces and exhibited
impaired arterial blood oxygen tensions (Figure 2B). Ex-
posure of toxin-injected mice to 60% oxygen, however, did
not result in death in the short-term assays we used.
These observations confirmed the prediction that inflamed
lung injury is exacerbated by oxygenation; however, the
development of therapeutic countermeasures requires testing
of the validity of our underlying assumptions and conclusive
identification of the molecular mechanisms of these proin-
flammatory effects of oxygen.
Figure 1. Increased Death Rate upon Oxygenation of Mice with Acute
Lung Injury
Mice were IT injected with SEB and LPS to model polymicrobial
infection and were exposed to 21% or 100% oxygen for 48–60 h.
Determination of time-dependent survival curves was prohibited by
considerations of unrelieved severe respiratory distress in NIH-
approved animal care protocol, which required termination of
experiments immediately after differences between groups became
apparent. Major differences between groups occurred within 48–60
hours after IT injection of toxins, when the majority of oxygenated
animals with inflamed lungs had died, while the nonoxygenated,
obviously sick control mice with inflamed lungs were still alive.
DOI: 10.1371/journal.pbio.0030174.g001
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Oxygenation Disrupts the Hypoxia fi A2AR-Mediated
Pathway
The observed effects of oxygenation could not be
accounted for by direct toxic effects of oxygen, since these
effects of oxygen take much longer to manifest [2, 14, 15] and
therefore are unlikely to fully account for the dramatic lung
injury observed in our short-term experiments (Figures 1 and
2).
To test whether oxygen enhances inflammatory tissue
damage by eliminating the hypoxia fi adenosine fi A2AR
pathway, which is hypothesized as being responsible for
protecting inflamed lungs and down-regulating neutrophils,
we (i) determined the role of neutrophils in inflammatory
lung injury, (ii) tested for A2AR expression on these cells to
demonstrate their susceptibility to modulation by endoge-
nously produced adenosine, (iii) analyzed the degree of
inflammatory lung tissue damage in A2AR gene-deficient
mice or in wild-type mice treated with highly selective
pharmacologic antagonists for A2ARs, and (iv) tested whether
the hypoxia has a lung-protective role and whether there is a
direct linkage between hypoxia (upstream) and A2ARs (down-
stream) in the proposed lung-protective hypoxia fi A2AR
pathway.
To diminish the suffering of animals with severely inflamed
and damaged lungs, in the experiments described in the next
section we used the less-severe lung injury model established
by the injection of LPS alone instead of the polymicrobial
(SEB þ LPS) model of lung damage.
Neutrophils Are Involved in Inflammatory Lung Injury and
Are Inhibited by A2ARs
In agreement with an important pathogenic role for
granulocytes in acute lung injury [16, 17], we confirmed that
inflammatory lung injury elicited by IT injection of LPS in
wild-type mice is in large part mediated by granulocytes,
because the depletion of polymorphonuclear leukocytes
(PMNs) with the anti-Gr-1 monoclonal antibody resulted
not only in a substantial decrease in the number of cells in the
BAL fluid but also in a much less pronounced endotoxin-
induced lung injury (Figure 3A). This finding was further
supported by the correlation between the number of PMNs
and the degree of lung vascular permeability as reflected by
the amount of protein recovered from the alveolar space by
BAL (Figure 3B).
To answer the question of whether murine neutrophils are
susceptible to inhibitory effects of endogenously produced
adenosine via A2AR signaling, we characterized the effects of
increasing concentrations of the highly specific A2AR agonist
CGS21680 on the oxygen radical production of granulocytes
taken from the blood of healthy mice. Surprisingly, respira-
tory burst activity of such ‘‘naı¨ve’’ granulocytes was only
poorly inhibited by A2AR signaling (Figure 4A, left graph).
Therefore it was important to test whether ‘‘in vivo-
activated’’ granulocytes isolated from inflamed lungs of IT
LPS-injected mice might have up-regulated their A2AR
expression. As expected, significant up-regulation of A2AR
was observed in experiments in which CGS21680 greatly
enhanced the chemotactic peptide N-formyl-methionyl-leu-
cyl-phenylalanine (fMLP)-stimulated cAMP production of in
vivo-activated neutrophils isolated from inflamed lungs from
wild-type mice, but not of naı¨ve granulocytes obtained from
the bone marrow of healthy wild-type control mice (Figure
4B, left graph). In a genetic control, the cAMP increase was
absent in in vivo-activated granulocytes from A2AR gene-
deficient mice (Figure 4B, right graph). In addition, the
adenosine-induced cAMP increase was inhibited in wild-type
granulocytes by the selective antagonist of A2ARs ZM241385
(Figure 4B, right graph). Results of parallel assays confirmed
increased expression of A2AR on activated granulocytes, since
CGS21680 inhibited the functional response of in vivo-
activated granulocytes (i.e., as evidenced by the production of
Figure 2. Exacerbation of Inflammatory Lung Injury after Exposure of
Mice to Different Concentrations of Oxygen
(A) Enhanced lung vascular permeability (left graph) and impairment
of lung gas exchange (right graph) in mice breathing 100% O2 upon
induction of acute lung injury. Following IT injection of mice with
SEB and LPS, animals breathed 21% or 100% oxygen. After 48 h,
lung vascular permeability and lung gas exchange were determined
by the amount of protein recovered by BAL or by measuring pO2
values in arterial blood drawn, respectively, 15 min after return of
mice to normal atmosphere. During this equilibration period, three
out of seven mice previously exposed to 100% oxygen died, so that no
arterial blood gas analyses could be performed, but BAL protein
concentrations were determined immediately thereafter.
(B) Increased lung vascular permeability (left graph) and impairment
of lung gas exchange (right graph) in mice with acute lung injury even
upon exposure to lower levels of oxygen (60%), which are considered
clinically safe in humans. Experimental conditions were the same as
in (A), except oxygen concentration was 60% instead of 100%.
DOI: 10.1371/journal.pbio.0030174.g002
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tissue-damaging reactive oxygen species) much more strongly
than in naı¨ve cells (Figure 4A, right graph).
The results of mRNA expression studies were in agreement
with above functional studies of adenosine receptors, and a
much stronger increase in A2AR mRNA levels was observed in
in vivo-activated PMNs than in naı¨ve cells, with only small
changes in A1 receptor mRNA expression in the first
experiment (Figure 4C, left graph). These findings were
further confirmed in a second experiment in which the effect
of 100% oxygen was compared to that of normal atmosphere
(Figure 4C, right graph). When compared to the several-fold
increase in A2AR mRNA expression levels in inflammatory
granulocytes from mice exposed to 21% oxygen, these levels
were up-regulated to a much lesser extent in mice breathing
100% oxygen. As in the first experiment, no changes were
observed in A3 mRNA expression, while expression of A2B
receptors showed changes similar to those of A2AR mRNA
(unpublished data). Interestingly, the expression of A1 mRNA
levels was increased in inflammatory lung granulocytes
obtained from hyperoxic animals. Thus, the decreased up-
regulation of A2AR-specific mRNA that was observed in
parallel with an increased A1 receptor-specific mRNA
expression in inflammatory granulocytes from mice breath-
ing pure oxygen is in support of hyperoxic exacerbation of
lung injury.
A2ARs Protect Lung Tissue from Inflammatory Damage
The genetic evidence for the critical role of A2AR in lung
protection was provided by the observation of many more
PMNs in BAL from A2AR-deficient mice than in BAL from
similarly treated wild-type mice (Figure 5A). This was
accompanied by an increase in lung vascular permeability
as reflected by enhanced BAL protein levels in A2AR-deficient
mice and a decrease in overall lung function, which was
manifested by a decrease in arterial blood oxygen tension as
compared to wild-type mice.
In agreement with the genetic evidence in Figure 5A,
similar proinflammatory changes in numbers of granulocytes,
levels of protein, and values of lung gas exchange were
observed after pharmacological inactivation of A2AR with the
antagonist ZM241385 (Figure 5B).
These observations establish that the A2AR is critical in
limiting inflammatory lung injury; even higher lung injury
would have resulted from the inflammatory stimuli we used,
were it not for the lung protection in wild-type mice due to
the inhibition of neutrophils by a functional hypoxiafi A2AR
pathway.
Hypoxia Down-Regulates Neutrophils and Protects Lung
Tissue from Inflammatory Damage
To test whether anti-inflammatory lung-protective effects
can be induced in mice by allowing them to breathe a hypoxic
gas mixture, LPS-injected wild-type mice were exposed to
10% oxygen. Although this oxygen concentration was
sublethal for LPS-injected mice, we chose to study the effects
of this degree of hypoxia because 15% of ARDS patients die
from therapy-refractory hypoxemia [18]. Accordingly, some
deaths occurred in IT LPS-injected mice at hour 4–7 of
hypoxic exposure. In the majority of surviving mice (over
90%), however, hypoxia for 48 h strongly inhibited acute
neutrophilic inflammation and led to overall better lung
protection compared to mice kept at 21% oxygen. This
improvement was evidenced by a decreased pulmonary
sequestration of PMNs (Figure 6), inhibition of their
capability to produce oxygen-reactive metabolites (Figure
6A), decreased protein accumulation (Figure 6B), and better
lung function as reflected in higher arterial pO2 levels (Figure
6A). This conclusion was further confirmed by histological
studies (Figure 6C) that revealed not only a decrease in PMN
sequestration, but also a significant decrease in parameters of
Figure 3. Role of PMNs in the Pathogenesis of LPS-Induced Lung Injury
(A) Depletion of granulocytes attenuates the endotoxin induced rise
in alveolocapillary permeability. Pretreatment of mice with anti-Gr-1
was followed by a significant decrease in the number of granulocytes
(left graph) and a significant reduction of the total amount of protein
(right graph) recovered by BAL 48 h after IT LPS injection.
(B) The more granulocytes immigrated into the alveolar spaces, the
higher the alveolocapillary permeability rose. Bivariate analysis
according to Pearson revealed a statistically significant correlation
(p , 0,001) between the number of PMNs and the amount of protein
in the BAL fluid 48 h after IT LPS injection, suggesting that
inflammatory lung injury after IT injection of LPS is mostly mediated
by granulocytes.
DOI: 10.1371/journal.pbio.0030174.g003
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lung tissue damage as evidenced by the 7-fold reduction of
the lung injury score (LI; Figure 6C).
Taken together, these data strongly suggest that tissue
hypoxia is important in protecting pulmonary tissues from
additional inflammatory damage.
Hypoxia and A2AR-Triggered Signaling Function in the
Same Lung Tissue-Protecting Pathway
It was important to establish whether inflamed and hypoxic
lung tissues are protected by enhanced adenosine formation
and subsequent A2AR engagement or by an anti-inflammatory
role of a yet-to-be-uncovered hypoxia fi unknown endoge-
nous anti-inflammatory molecule ‘‘X’’-mediated pathway. To
distinguish between these two possibilities we tested the
effects of genetic deficiency of the A2AR on inflammatory
lung injury in hypoxic conditions.
Exposure of healthy wild-type mice to 10% oxygen resulted
in a drop of arterial blood pO2 values to levels observed
during severe hypoxemia (Figure 7A, left graph). As a result of
insufficient systemic oxygen delivery and resulting hypoxe-
mia, breathing of 10% oxygen caused an increase in
production of endogenous adenosine, shown by the rise of
extracellular plasma concentrations of the nucleoside (Figure
7A, right graph).
Hypoxic (10%) oxygen was also expected to provide an
important readout of the degree of lung injury by the level of
survival in the mice. In our experiments, the dose of LPS
injected IT induced much higher levels of lung injury in
A2AR-deficient mice than in control wild-type mice (see
Figure 5), but neither wild-type or A2AR deficient mice died if
they were kept at 21% oxygen at these levels of lung injury.
Different outcome with respect to death rates were
expected, if A2AR-deficient and wild-type mice with LPS-
inflamed lungs were kept at 10% oxygen. We reasoned that
Figure 4. Evidence for the Up-Regulation of Immunosuppressive A2AR
Expression on In Vivo-Activated Granulocytes Isolated from Inflamed
Lungs
(A) The selective A2AR agonist CGS21680 inhibited the fMLP-
stimulated hydrogen peroxide production by granulocytes in blood
of healthy mice to only a small degree, reflecting low levels of
expression of A2AR on naı¨ve blood granulocytes. In contrast,
granulocytes recovered by BAL from inflamed lungs 48 h after IT
LPS injection were much more inhibited by CGS21680, demonstrat-
ing functional up-regulation of A2AR on in vivo-activated cells.
(B) CGS21680 induces cAMP accumulation in in vivo-activated
granulocytes isolated from lungs 48 h after IT LPS injection. No
effects of the A2AR agonist were observed in naı¨ve granulocytes
obtained from bone marrow of healthy mice (left graph) or in in vivo-
activated granulocytes recovered from inflamed lungs of A2AR gene-
deficient mice (right graph). The CGS21680-stimulated cAMP
production observed in lung granulocytes obtained from wild-type
mice could also be antagonized by the selective A2AR antagonist
ZM241385. Naı¨ve bone marrow granulocytes were used for cAMP
measurements, since it was impossible to isolate naı¨ve cells from
blood of healthy mice in sufficient numbers.
(C) Higher levels of A2AR-specific mRNA in in vivo-activated
granulocytes. In parallel with the much stronger A2AR agonist-
induced inhibition of hydrogen peroxide production and accumu-
lation of cAMP in in vivo-activated granulocytes, the relative levels of
A2AR-specific mRNA were much higher in in vivo-activated gran-
ulocytes obtained from inflamed lungs 48 h after IT LPS injection, as
compared with naı¨ve granulocytes isolated from the bone marrow of
healthy mice (left graph). Up-regulation of A2AR mRNA in in vivo-
activated granulocytes was confirmed in another set of experimental
animals breathing 21% oxygen, but was increased to a much lesser
extent in animals subjected to 100% oxygen (right graph). Levels of
A1R mRNA did not change much in inflammatory lung granulocytes
from animals breathing normal atmosphere, but were clearly
increased in mice exposed to 100% O2. In the two sets of experiments
(left and right graphs), granulocytes were pooled from five and six
mice per treatment, respectively. Taken together, the results
demonstrate that granulocytes recovered from alveolar spaces of
inflamed lungs did, indeed, up-regulate their A2AR expression during
these in vivo lung injury assays, thereby confirming and extending
previous findings in other inflammation models [11, 53]
DOI: 10.1371/journal.pbio.0030174.g004
PLoS Biology | www.plosbiology.org June 2005 | Volume 3 | Issue 6 | e1741092
Oxygen Exacerbates Acute Lung Injury
under these conditions the A2AR-deficient mice would have
much more pronounced pulmonary inflammation and hence
less healthy lung tissues left to adequately oxygenate vital
organs. Thus, the interruption of the hypoxia fi A2AR
pathway and the resulting uninhibited inflammatory pro-
cesses and increased lung damage would lead to accelerated
death of A2AR-deficient mice in 10% oxygen.
In contrast, these treatments would not result in pro-
nounced lethality in lung-inflamed wild-type mice at 10%
oxygen tension, because wild-type mice benefit from their
lung-protecting hypoxia fi A2AR pathway and would have
much larger portions of still-healthy lungs left to ensure
sufficient oxygen supply to tissues.
Accordingly, we predicted that the majority of A2AR
genetically deficient mice would die at 10% oxygen, while
the majority of wild-type mice would survive. This prediction
was based on the assumption that the hypoxia fi A2AR
pathway is nonredundant and would not be substituted by
another hypoxia fi ‘‘X’’ molecule receptor pathway.
These expectations were confirmed by the data showing
that exposure of the IT LPS-injected wild-type mice to
hypoxia resulted in low mortality (only 20% [4 out of 20] of
the mice died), whereas in the parallel group all (20 out of 20)
similarly treated A2AR-deficient mice died (Figure 7B).
Control experiments with healthy, non-LPS treated, wild-
type and A2AR-deficient mice subjected to hypoxia demon-
strated that deficiency in the A2AR did not cause death per se,
because all mice survived (unpublished data).
These observations of survival were further supported by
measurements of BAL and plasma levels of the cytokines
tumor necrosis factor a (TNF-a) and interleukin 6 (IL-6), and
the chemokine major intrinsic protein 2a (MIP-2a), all of
which are considered to be early mediators of lethal
endotoxic shock [19, 20]. Accordingly, the outcome of survival
experiments (Figure 7B) was in agreement with that from
higher concentrations of TNF-a, IL-6, and MIP-2a in hypoxic
(10% oxygen) A2AR-deficient mice as compared to hypoxic
wild-type mice 2 h after IT LPS injection (Figure 7C). No time
points after 2 h could be compared in wild-type versus A2AR-
deficient mice, because A2AR knockout mice started to die
soon after IT LPS-injection (Figure 7B).
Interestingly, the increase in hypoxia A2AR-controlled
TNF-a levels was accounted for by local accumulation in
the lung, because BAL concentrations of this cytokine were
on average ten times higher than in the systemic circulation,
although the BAL volume was at least three times higher than
that of a mouse’s blood. By contrast, levels of IL-6 and MIP-2a
were much higher in the systemic circulation, suggesting that
TNF-a BAL levels may serve as a useful marker for lung
inflammation (Figure 7C). Moreover, the results shown in
Figure 7D support the view that pulmonary proinflammatory
cytokine TNF-a levels are indeed under the negative control
of the hypoxia fi A2AR pathway. This is supported by data
showing no differences in BAL TNF-a concentrations
between A2AR gene-deficient mice breathing either 10% or
100% oxygen. In contrast, the BAL TNF-a concentrations
were significantly lower in hypoxic wild-type mice (with
functioning hypoxia fi adenosine fi A2AR pathway) than in
mice breathing pure oxygen (Figure 7D).
Taken together, these experiments support the view that
both hypoxia and A2AR are needed to down-regulate lung
inflammation, and that oxygenation exacerbates lung injury
due to interruption of the tissue-protecting hypoxia fi A2AR
anti-inflammatory pathway. Thus, these observations leave no
room for yet another lung tissue-protecting hypoxia fi X
receptor signaling pathway in tested experimental condi-
tions. This knowledge suggested a direct and effective
therapeutic countermeasure to reap benefits of oxygenation
Figure 5. Evidence for the Critical Role of Immunosuppressive A2AR in
Lung Protection from Inflammatory Damage
(A) In A2AR gene-deficient mice, number of PMNs (left graph) and
amount of protein recovered (center graph) 48 h after IT LPS
injection by BAL was significantly higher than in similarly treated
wild-type control mice, reflecting increased lung damage in the
absence of A2AR. The arterial oxygen tension (right graph) was lower
in A2AR gene-deficient mice as compared with wild-type mice.
(B) Pharmacologic inactivation of A2AR leads to exacerbated
inflammatory lung tissue damage and decreased lung funciton. After
estimation of biologically relevant half-life of A2AR antagonist
ZM241385 (ZM) in vivo (unpublished data), the IT LPS-injected mice
were administered ZM241385 at a dose of 10 mg/kg body weight every
6 h subcutaneously to ensure sufficient levels of the antagonist. This
dosing regimen of the A2AR antagonist caused significant more lung
tissue damage, as reflected by increased number of PMNs (left graph)
and protein levels (center graph) in the BAL fluid obtained after 48 h.
In parallel experiments, the A2AR antagonist decreased lung function
(right graph) as compared to untreated wild-type mice, in agreement
with results of experiments with A2AR gene-deficient mice.
DOI: 10.1371/journal.pbio.0030174.g005
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without sacrificing still-healthy lung tissues to continuing
inflammatory damage: use of the A2AR agonist CGS21680.
An A2AR Agonist Compensates for the Loss of Lung-
Protective Mechanisms and Prevents Death
Figure 8 shows that IT injections of the selective A2AR
agonist CGS21680 significantly inhibited lung injury in LPS-
treated mice. This treatment led to (i) significantly decreased
accumulation of PMNs (Figure 8A), (ii) reduced production of
reactive oxygen metabolites (Figure 8A), (iii) less-pronounced
increases in lung vascular permeability (Figure 8B), and (iv)
improved lung gas exchange (Figure 8B). Histological
examination of CGS21680-treated mice revealed that ther-
apeutic effects of the agonist were similar to those of
exposure of mice to hypoxia. CGS21680 treatment resulted
in inhibition of pulmonary PMN sequestration (Figure 8C),
and—as shown for hypoxia above—was followed by a
significant reduction of lung tissue damage as assessed by
the 4-fold decrease in the LIS (Figure 8C).
Treatment with CGS21680 was effective even when applied
in the more severe polymicrobial toxin model of lung injury
(i.e., LPSþSEB); IT injections of this agonist under hyperoxic
conditions rescued the majority of mice from oxygenation-
induced death. The death rate was 80% among oxygenated
mice with inflammatory lung injury in the control group, but
dramatically less among those treated with the A2AR agonist
(Figure 9).
Thus, the exogenously added, selective, synthetic A2AR
agonist compensated for the loss of endogenously formed
adenosine in oxygenated inflamed lungs, thereby decreasing
lung injury and rescuing mice from death. In an important
control, CGS21680 at the dosing regimen used to treat wild-
type mice was proven to be selective, since it did not affect
lung inflammation in A2AR gene-deficient mice (unpublished
data).
Discussion
The oxygenation of hypoxic patients with impaired lung
function is an important and life-saving therapeutic measure,
but 15% of patients with ARDS still die from treatment-
refractory hypoxia [18]. We here provide evidence supporting
Figure 6. Hypoxia Down-Regulates Neutrophils and Protects Lung Tissue
from Inflammatory Damage
(A) Exposure of IT LPS-injected mice to hypoxic (10%) oxygen levels
for 48 h atmosphere leads to a significantly decreased accumulation
of PMNs (left graph), production of LPS-triggered oxygen reactive
metabolites in lungs (center graph), and improved lung gas exchange
(right graph) compared to a control group of endotoxin-treated mice
that were kept at ambient (21%) oxygen. To standardize conditions,
the arterial blood samples were taken 15 min after return of the
previously hypoxia-exposed animals to normal atmosphere.
(B) Treatment by a shorter period of hypoxia attenuates PMN
sequestration (left graph) and lung vascular permeability (right
graph). Hypoxic treatment of mice even for only 24 h was sufficient
to delay PMN sequestration and to diminish the increase in lung
vascular permeability.
(C) Histologic evidence for the hypoxic inhibition of pulmonary PMN
sequestration. Quantitative analysis of lung slices by a pathologist
blinded to the experimental design revealed inhibition of PMN
sequestration in IT LPS-injected mice following 4-h exposure to
hypoxia. Hypoxia not only attenuated PMN accumulation, but the
lung tissue damage was also significantly decreased as assessed by the
LIS (n = 9, mean 6 standard deviation). The representative H&E-
stained slices in the right two photomicrographs show less intra-
vascular granulocyte sequestration, less thickening of the alveoloca-
pillary membrane, and almost no granulocytes in the alveolar spaces
as compared to IT endotoxin-injected animals breathing 21% O2.
These observations demonstrate that hypoxia also inhibited the
transmigration of granulocytes from capillaries into the alveolar
spaces.
DOI: 10.1371/journal.pbio.0030174.g006
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the hypothesis that, in a mouse model of lung inflammation,
while oxygenation relieves the immediate life-threatening
consequences of hypoxemia, it also further exacerbates acute
lung injury and even may lead to death due to the
interruption of the critically important, nonredundant
hypoxia fi adenosine fi A2AR-mediated lung-protecting
pathway. This conclusion is supported by (i) the strong
increase in lung inflammation and mortality after short-term
exposure of mice to high and even to moderately elevated
concentrations of oxygen (see Figures 1 and 2); (ii) the
causative pathogenic role of PMNs in inflammatory lung
injury (see Figure 3) and the up-regulation of A2AR
Figure 7. Hypoxia and Extracellular Adenosine A2AR Function in the Same Anti-Inflammatory, Lung Tissue-Protecting Pathway
(A) Effects of breathing hypoxic (10%) oxygen on arterial blood oxygen tension (left graph) and plasma adenosine concentration (right graph) in
healthy wild-type mice. As a control, data are also shown for healthy mice breathing 21% and 100% oxygen.
(B) No survival of A2AR gene-deficient mice was observed in acute hypoxic lung injury. Wild-type and A2AR gene-deficient mice were injected IT
with LPS and exposed to hypoxia (10%). While the majority of wild-type mice survived, all of the A2AR gene-deficient mice died, indicating that
expression of A2AR is required for survival of hypoxic lung inflammation; this experiment mimics the clinical situation in which lung
inflammation increases to such severity that hypoxia occurs.
(C) Significantly higher levels of pulmonary and systemic inflammatory cytokine production in hypoxic A2AR-deficient mice. Observations of
survival were supported by significantly higher BAL and serum (Se) levels of inflammatory cytokines in hypoxic A2AR-deficient mice compared
to hypoxic wild-type mice. Cytokines were determined 2 h after IT LPS injection, because A2AR-deficient mice started to die soon after LPS
administration and thus could not be used in comparative studies with wild-type control mice. The early mortality of A2AR-deficient mice also
did not allow the comparative determination of effects of hypoxia on other late markers of inflammation such as PMN accumulation, lung
vascular permeability, and pulmonary gas exchange, which in wild-type mice need about 48 h to develop after IT endotoxin injection.
(D) Degree of inflammation is independent from level of oxygen in A2AR-deficient mice but not in wild-type mice. While BAL fluid TNF-a
concentration determined 2 h after IT LPS injection was significantly suppressed in hypoxic wild-type mice compared to animals breathing
100% oxygen, hypoxia had no effect on TNF-a BAL concentrations in A2AR gene-deficient mice, demonstrating that suppression of TNF-a
formation by hypoxia is mediated through A2AR signaling.
DOI: 10.1371/journal.pbio.0030174.g007
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expression on alveolar PMNs (see Figures 4); (iii) the critical
role of A2AR in lung protection from enhanced accumulation
of PMNs as well as more pronounced vascular permeability
and stronger impairment of lung gas exchange in A2AR
genetically deficient mice (see Figure 5A) and in A2AR
antagonist-treated wild-type mice (see Figure 5B); (iv) the
strong lung-protective effects of hypoxia by suppression of
PMN emigration, PMN activation, lung vascular permeability,
and impairment of gas exchange in wild-type mice (see Figure
6); (v) the evidence that hypoxia is upstream of A2ARs in the
same anti-inflammatory, lung tissue-protecting pathway, as
shown by the failure of the adenosine-producing (see Figure
7A) hypoxia to protect A2AR-deficient mice from death and
excessive pulmonary TNF-a cytokine production (see Figure
7B–7D), and (vi) the confirmation of the hypoxia-elicited
lung-protective effects in wild-type mice by the A2AR agonist
CGS21680 (see Figure 8), which (vii) could rescue mice from
hyperoxia-accelerated death (Figure 9).
By confirming the molecular mechanism of the predicted
exacerbation of lung injury by oxygenation, this mechanism
also offers a direct and effective preventive measure by
compensating for the oxygenation-related loss of endogenous
adenosine. Accordingly, we suggest the reevaluation of
relevant ventilation and oxygenation protocols and the
consideration of compensatory therapeutic treatments of
oxygenated-inflamed lungs with A2AR agonists (reviewed in
[7]) to prevent uninterrupted inflammatory lung damage (see
Figure 8) and death (Figure 9). Other anti-inflammatory drugs
alone or in combination with an A2AR agonist should be also
considered in future refinements of this approach, because an
A2AR agonist offers the advantage of pharmacologically
restoring the physiological tissue-protecting pathway [4, 11,
12], which is unintentionally weakened by therapeutic oxy-
genation.
It is likely that these findings are most applicable to ARDS
patients, although other clinical situations in which inflamed
lungs are oxygenated should be also considered. The lungs of
ARDS patients are known to be heterogenously ventilated,
leaving substantial lung areas hypoxic with up to 33% of total
lung volume being nonaerated [21]. These are the most
damaged and therefore hypoxic lung regions, where—
counterintuitively—hypoxia may protect still-healthy sur-
rounding lung tissues from the additional inflammatory
Figure 8. Intratracheal Injection of A2AR Selective Agonist Mimics
Protective Effects of Hypoxia
(A) IT injection of the A2AR agonist CGS21680 into endotoxin-
inflamed lungs provides protection similar to that observed in
hypoxia-treated mice. Number of PMNs recovered after 48 h by BAL
from endotoxin-injected animals that were kept at normal 21%
oxygen atmosphere was significantly diminished by IT injections of
CGS21680 compared to placebo-treated mice. Lung PMNs (left
graph) from A2AR agonist-treated animals also produced lower levels
of reactive oxygen metabolites (H2O2; right graph).
(B) Significantly decreased lung vascular permeability (protein in
BAL; left graph) and improved lung gas exchange (paO2; right graph)
in endotoxin-injected mice after treatment with the A2AR agonist
CGS21680.
(C) Histologic evidence for the lung tissue-protecting effects of A2AR
agonist during endotoxin- and oxygenation-induced lung damage.
Quantitative analysis of lung histopathology by a pathologist blinded
to the experimental design revealed inhibition of PMN sequestration
in IT LPS-injected mice after treatment with the A2AR-selective
agonist CGS21680 for 48 h. The lung tissue damage was also
significantly decreased as assessed by the LIS (n = 9, mean 6
standard deviation). Representative H&E-stained slices in the right
two photomicrographs show less intracapillary PMN sequestration
and almost no intraalveolar accumulation of PMNs in CGS21680-
treated mice. These CGS21680-induced changes are similar to those
observed for the effects of hypoxia on endotoxin- injected animals
(compare with Figure 6C).
DOI: 10.1371/journal.pbio.0030174.g008
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injury by promoting formation of extracellular adenosine [8–
10] and strengthening the anti-inflammatory A2AR signaling
pathway [4–7, 11, 12]. Supportive ventilation to increase lung
tissue oxygen levels also eliminates the hypoxia-associated
formation of anti-inflammatory endogenous adenosine, and
this allows the unopposed continuation of the inflamed lung
destruction. Thus, a necessary medical intervention (oxygen-
ation of oxygen-deprived patients) may also cause an
iatrogenic exacerbation of the very condition that led to
the need for oxygenation in the first place. Such pathophy-
siological consequences of tissue oxygenation are expected to
be most pronounced in collapsed hypoxic lung areas that
would be recruited by any kind of ventilatory strategy [22].
In agreement with our findings are sporadic observations
of effects of oxygenation in other clinical human protocols
[23, 24] and experimental assays in animal models [25, 26]. For
instance, intraoperative administration of 100% oxygen
augmented proinflammatory cytokine production of alveolar
macrophages within 2–8 h of the start of anesthesia and
surgery in patients [23, 24]. Similarly, in animal models of
lung injury, a synergistic action between infectious agents
[25], bacterial toxins [26], or acid aspiration [27] and
hyperoxia was demonstrated and difficult to explain by
direct oxygen toxicity. Indeed, the time periods of these
effects were much too short for the manifestation of oxygen
toxicity, which usually takes more than 64–72 h to become
clinically apparent in mice [14]. Of note, in the same mouse
strain (C57BL/6) that we used in our studies, breathing of
pure oxygen did not result in death before the fourth day
[15].
Although it is likely that synergy between lung-damaging
noxious agents and oxygen is mediated by oxygen radicals
[27], the elimination by oxygenation of the natural anti-
inflammatory hypoxia fi A2AR signaling pathway was not
appreciated before, which may account for a significant
proportion of inflammatory complications in patients.
Our observations of potent anti-inflammatory effects of
hypoxia in lung injury (see Figures 6 and 7D) are in
agreement with previously published effects of hypoxia,
including significant attenuation of emigration of neutro-
phils to the site of inflammation in carrageenin-induced
pleurisy [28], inhibition of granulocyte adhesion to endothe-
lial cells [29], enhanced shedding of adhesion molecule
CD11b from PMNs [30], and suppression of cytokine
formation when PMNs are in contact with extracellular
matrix proteins [31]. Use of cd39- and cd73-null animals
revealed that extracellular adenosine produced through
adenine nucleotide metabolism during hypoxia is a potent
mechanism attenuating excessive tissue PMN accumulation
[9]. Hypoxia was also shown to strongly inhibit production of
MCP-1 [32], IL-1b [33], granulocyte-macrophage colony-
stimulating factor [34], and induced down-regulation of
cosignaling molecules (CD80) [35]. Hypoxia was further
shown to cause decreased expression of Toll-like receptor 4
receptors by inhibiting translocation of activator protein 1
[36] and caused suppression of Escherichia coli-induced nuclear
factor jB and activator protein 1 transactivation [37]. Finally,
hypoxia was shown to stimulate phosphatidylinositol 3-kinase
activity and thereby protect human lung microvascular
endothelial cells and epithelial type II-like A549 cells from
subsequent oxygen toxicity [38].
However, hypoxia was also shown to exert some proin-
flammatory effects in vitro [39] and in vivo [9, 40, 41] for time
intervals ranging from 3 to 12 h, which may not reflect the
long-term effects of hypoxia on inflammatory processes as
assessed in our study.
Importantly, the virtually complete lung protection from
the proinflammatory effects of 100% oxygen by an immuno-
suppressive A2AR agonist (Figure 9) supports the view that
exacerbation of lung damage by 100% oxygen could be
almost fully accounted for by immune mechanisms in
addition to mechanical [42,43] or radical-mediated mecha-
nisms of lung injury [2]. It remains to be determined,
however, whether the much longer time course of the direct
toxicity of 100% oxygen in healthy, noninflamed lungs could
be explained by the recruitment of immune cells [44], which
then, in turn, would exacerbate the 100% oxygen-triggered
lung tissue damage through prolongation of trauma-initiated
inflammation.
Finally, the observations and conclusions of this report may
have implications for the widely used therapeutic oxygen-
Figure 9. IT Administration of A2AR Agonist Protects from Increased
Death Rate upon Oxygenation of Mice with Acute Lung Injury
Compensation for the oxygenation-associated loss of the hypoxia fi
adenosine fi A2AR signaling pathway by IT injection of CGS21680
significantly decreased the oxygen-exacerbated death rate in mice
with acute lung injury induced by IT injection of SEB and LPS. For
further explanation, see legend for Figure 1.
DOI: 10.1371/journal.pbio.0030174.g009
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ation in patients with lung injury, and may answer the long-
standing question as to why lungs are the most susceptible to
inflammatory injury and why lung failure usually precedes
multiple organ failure [45, 46]. We propose that the diseased
lung might be uniquely susceptible to iatrogenic damage by
oxygenation, because the lungs are exposed to the highest
levels of oxygen tension of all organs. Therefore, this critical,
A2AR signaling-mediated, hypoxia-driven, lung tissue-pro-
tecting anti-inflammatory mechanism is the most vulnerable
to elimination by oxygenation in the hypoxic areas of
damaged lung as compared to other vital organs.
Materials and Methods
Mice. Female 6- to 8-wk-old C57BL/6 A2AR gene-deficient mice
(N10) and age-matched wild-type mice were maintained in pathogen-
free NIH animal facilities. The A2AR genotypes of mice were
determined by Southern blot analysis as described previously [47].
All animal study protocols were approved by the NIH Animal Care
and Use Committee.
IT administration of LPS and SEB. Female C57BL/6 mice were
anesthetized by isoflurane anesthesia. Using a modified transtracheal
illumination technique [48], mice were nontraumatically intubated by
intratracheal insertion of a 24-gauge catheter (Abbocath-T, Abbott
Ireland, Ireland) via direct laryngoscopy. SEB was injected IT at a
dose of 1 mg/kg body weight in a total volume of 50 ll per mouse.
After IT injection of unconscious but spontaneously breathing mice,
animals were held in an upright position for 15 s and then briefly
shaken in all directions to ensure homogenous fluid dispersion in the
lung. After 1 h, mice were anesthetized again with isoflurane and
injected with LPS at a dose of 4 mg/kg body weight in a total volume
of 50 ll per mouse. The injected fluid was dispersed by the same
positioning maneuver as applied for the intrapulmonary distribution
of SEB. Control, sham-treated mice were intubated and injected with
only the solvent that was used to inject toxins, i.e., phosphate-
buffered saline.
LPS administration. LPS was IT injected at a dose of 2 mg/kg body
weight in a total volume of 50 ll per mouse under isoflurane
anesthesia using the same technique as described above.
Depletion of granulocytes in mice. Mice were depleted in
granulocytes by two IV injections of anti-GR-1 monoclonal antibody
at a dose of 1 mg/kg body weight, administered 24 h before and briefly
before IT injection of LPS. Control animals received isotype-matched
antibody at the same dose and intervals.
In vivo administration of A2A receptor agonist and antagonist. The
A2AR agonist CGS21680 was dissolved in PBS and administered by IT
injection at 0,1 mg/kg body weight in a total volume of 50 ll per
mouse. IT injection of CGS21680 was repeated every 8 h until
termination of the experiment. In control animals, the solvent of
CGS21680, i.e., PBS only, was administered in the same way and on
the same schedule. CGS21680 solution or solvent were injected
within 15 min of administration of SEB and/or LPS in both models of
lung injury. In studies using ZM241385, the A2AR antagonist was
injected subcutaneously at a dose of 10 mg/kg body weight every 6 h
until the end of the experiment. ZM241385 was dissolved in DMSO
(10 mg/145 ll of DMSO) and then further diluted in 14,8 ml of PBS,
yielding a 2 mM working concentration of which a volume of
approximately 250–300 ll was injected per mouse. Control animals
received the same volume of the solvents only. ZM214385 or control
solution were injected subcutaneously 30 min before IT LPS
administration. According to the pharmacokinetics of subcutane-
ously injected ZM214385 at 10 mg/kg body weight, plasma concen-
trations of the antagonist were higher than 50 nM, even 6 h after its
administration. This concentration of ZM241385 is sufficient to exert
maximum pharmacologic antagonism on the adenosine-induced
cAMP response in murine thymocytes (for determination of
pharmacokinetics of ZM214385 see also ‘‘Modulation and measure-
ment of cAMP production of PMNs by A2AR stimulation and
antagonism in vitro,’’ below).
Control of fraction of inspired oxygen. In order to modify the
fraction of inspired oxygen, mice were placed in airtight modular
incubation chambers (Billups-Rothenberg, San Diego, California,
United States), and the atmosphere was controlled by a constant gas
flow (1,5 l/min) of desired composition (10% O2, 60% O2, or 100%
O2). To prevent any CO2 retention in the chambers, the chambers’
bottom was covered with approximately 250 g of anesthetic CO2
absorber material (Sodasorb, Grace & Co, Chicago, Illinois, United
States). Composition of gas atmosphere was tested intermittently by
analyzing pCO2 and pO2 values in an equilibrated fluid sample drawn
from a tube inside the chamber whenever the latter was opened for
reinjection of mice. During the stay of mice in chambers, animals
were fed and given fluids by offering them Transgel (Charles River
Laboratories, Wilmington, Massachusetts, United States).
Assessment of lung gas exchange and oxygen tension in peripheral
blood. At the end of the experiments, arterial blood specimen from
the tail artery were sampled directly into heparinized glass capillaries
that were closed on both ends with Parafilm and kept on ice until
further analysis (Rapidlab 248 system; Chiron Diagnostics, Essex,
United Kingdom).
Histological analysis. IT LPS-injected mice were sacrificed by
Table 1. Determination of Lung Injury Score
Parameter Degree of Severity
0 1 2 3
Interstitial edema formation According to the thickness of alveolar septal membranes
Activation of MØ MØ adherent to
alveolar
membranes, no
intraalveolar
accumulation in
alveoli
MØ start to lose
contact with
alveolocytes,
single cells
located
MØ more
frequently
found in alveoli
MØ most
frequently
found in groups
in alveoli
Activation of
endothelial cells
Endothelial cells
are flat and
adhere to
alveolocytes
Hyperchromatic,
enlarged nucleus
Hobnail
phenomenon,
cytoplasmic
vacuoles
Pronounced
hobnail
phenomenon
cytoplasmic
vacuoles, start
of cellular
disintegration
Leukocyte
adhesion to
endothelial cells
None Only a few
leukocytes
adhere
Groups of
leukocytes
adhere
Leukocytes
adhere to entire
vessel
circumference and start to
transmigrate
MØ, macrophages.
DOI: 10.1371/journal.pbio.0030174.t001
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isoflurane anesthesia, and the trachea was surgically exposed and
cannulated with a 20-gauge needle. The thoracic cage was opened to
allow lungs to expand during injection of 1 ml of 4% paraformalde-
hyde. After 15 min, the lungs were removed and fixed in 4%
paraformaldehyde until processing and H&E staining (American
Histolabs, Washington, Maryland). Quantitative analysis of lung
neutrophil sequestration was performed as previously described
[49], and lung tissue injury was semiquantitatively assessed in a
blinded fashion by a professional pathologist (I. Bittmann, MD). Lung
slices of IT LPS-injected groups of mice were first assessed for
pathological changes in general, enabling identification of lung
inflammation parameters to be further evaluated in a semiquanti-
tative way by assignment of four degrees of increasing severity.
Overall assessment of slides showed acute blood congestion, intra-
septal and intraalveolar neutrophil sequestration, interstitial edema,
intraalveolar macrophage accumulation, pneumocyte type II activa-
tion, endothelial cell activation, and endothelial adherence of
leukocytes. No intraalveolar edema and no fibrin deposits were
observed. Lung tissue injury was then evaluated by assignment of
four degrees of severity (0–3) to the following parameters in H&E
stained lung slides: interstitial edema formation, intraalveolar
macrophage accumulation, pneumocyte activation, endothelial cell
activation, and leukocyte adhesion to endothelial cells. The lung
injury score of each lung slice was calculated as an average of each
parameter’s degree of severity, ranging from 0 for a healthy lung to
15 (= 5 3 3) for a maximally injured lung. Further details on
definition of degrees of severity of pathological changes of each
parameter are described in Table 1.
BAL and cellular differentials. Following sacrifice and surgical
preparation of mice as outlined above for histological analysis, except
the opening of the thoracic cavity, lungs were lavaged by injection of
0,6 ml of ice-cold HBSS, which after each collection was repeated
four times. The recovered (over 90%) BAL fluid was processed for
total cell counts and cellular differentials. Contaminating erythro-
cytes were lysed by 0,01% saponin, and total leukocytes counted with
a Neubauer chamber. Differential counts were performed after
cytospin onto glass slides and staining with Hema-3 stain. The
remaining bronchoalveolar fluid was spun down and the supernatant
collected for determination of protein concentration using the Bio-
Rad Protein Assay (Bio-Rad, Hercules, California, United States)
according to the manufacturer’s manual. The cell pellet was used for
flow cytometric detection of hydrogen peroxide production by
neutrophils.
Flow cytometric determination of hydrogen peroxide production
by activated PMNs. BAL cells or whole blood, the latter withdrawn
from the tail vein and diluted in ice-cold heparinized (40 IE/ml)
HBSS, were washed two times with HBSS (0 8C). Cell pellets were
resuspended in HBSS containing dihydrorhodamine (2,5 lM). For
measurement of spontaneous hydrogen peroxide production by
oxidation of dihydrorhodamine to fluorescent rhodamine, cells were
either left on ice or incubated at 37 8C for 30 min, then returned
thereafter to ice. In parallel experiments designed to test the effects
of CGS21680 on blood granulocytes, cells were preincubated with
LPS (10 lg/ml) in the absence or presence of the A2AR agonist for 15
min, then stimulated by addition of the chemotactic tripeptide fMLP
(10 lM). When pharmacologic effects of CGS21680 were tested on
BAL granulocytes, no LPS was added. Cells were washed two times
with ice-cold PBS that contained bovine serum albumin (0,5%). FcgII/
III receptors were blocked by anti-mouse CD16/CD32 (10 min, 1 mg/
ml) and cells were incubated with PE-anti-mouse Ly6G (Gr-1) (15 min,
0,5 mg/ml). After washing with PBS, cells were subjected to flow
cytometry. Granulocytes were identified by staining for Gr-1 on Fl-2.
Hydrogen peroxide production was determined by the fluorescence
intensity of rhodamine on Fl-1. Appropriate compensation was set on
fluorescence channels to avoid signal overlap. All data were collected
in the log-amplified mode, and readings linearized using CellQuest
software (Becton Dickinson, San Diego, California, United States).
Spontaneous activity was calculated by subtraction of values of cells
kept on ice from those incubated at body temperature. Chemotacti-
cally induced activity was determined by subtraction of values
obtained at body temperature from those after addition of fMLP.
Preparation of granulocytes from bone marrow. Bone marrow was
removed from femur and tibia by injection of HBSS medium, washed
two times, and resuspended in HBSS medium. Remaining red blood
cells were removed by dextran sedimentation, and neutrophils were
recovered by discontinuous Ficoll density gradient centrifugation.
Purity of cells (over 90% granulocytes) was checked and further used
for cAMP and adenosine receptor mRNA determination as outlined
below.
Modulation and measurement of cAMP production of PMNs by
A2AR stimulation and antagonism in vitro. In vivo-activated
granulocytes recovered by BAL from inflamed lungs or naı¨ve
granulocytes obtained from bone marrow of healthy mice were
incubated in the presence of rolipram (1 lM, 37 8C, 30 min) and
activated with fMLP (10 lM) in the absence and presence of
increasing concentrations of the A2AR agonist CGS21680. Specificity
was tested by either pharmacological antagonism (A2AR antagonist
ZM241385 1 lM) or using cells from A2AR
/ mice. After 2 min of
chemotactic activation, cAMP metabolism was stopped by addition of
HCl and putting cells on dry ice. Cell suspensions were kept frozen
(80 8C) until analysis of cAMP levels as previously described [50].
Freshly prepared thymocytes from wild-type mice in which cAMP
production was induced by CGS21690 (10 lM) in the absence or
presence of ZM241385 were used as a positive control. Since
ZM241385 concentration-dependently decreased the cAMP produc-
tion of thymocyte elicited by A2AR activation with a fixed concen-
tration of adenosine, the system was also used to determine the
plasma concentrations of ZM241385 during the in vivo treatment of
mice with the antagonist (unpublished data).
Determination of A1R- and A2AR-specific mRNA levels in PMNs.
Quantification of A1- and A2AR-specific mRNA levels were deter-
mined in naı¨ve or in vivo-activated granulocytes according to the
method published previously [51].
Blood sampling and determination of plasma concentrations of
adenosine. Arterial blood samples were drawn from anesthetized
mice by cardiac puncture using ice-cooled syringes pre-filled with a
stop solution containing EHNA (20 lM), dipyridamole (200 lM),
EDTA-Na2 (20 mM), EGTA (20 mM), and dl-a-glycerophosphate to
prevent degradation or additional formation of plasma adenosine.
Mice were breathing 21% oxygen or 10% oxygen atmosphere at least
5 min before cardiac blood sampling. By obtaining arterial blood
samples from the left ventricle, the loss of the adenosine due to its
rapid degradation by adenosine deaminases was minimized and
plasma concentrations of adenosine better reflected those in lung
tissue, although local levels of adenosine in hypoxic tissues are
expected to be much higher. Drawn samples were processed and
plasma concentrations of adenosine determined by HPLC as
previously described [52].
Reagents. SEB was obtained from Toxin Technology (Sarasota,
Florida, United States). LPS (E. coli E055:B5) and HBSS were
purchased from Sigma Chemicals (St. Louis, Missouri, United States)
and supplemented by 1 mMMgCl2 and 1 mM CaCl2 freshly before use.
Dihydrorhodamine was purchased from Molecular Probes (Eugene,
Oregon, United States). PE-labeled anti-mouse Ly6G (Gr-1) antibody
and isotype control antibody were obtained from Caltag Laboratories
(Burlingame, California, United States). Fc-receptor-blocking anti-
CD16/CD32 antibodies were purchased from BD Biosciences Phar-
mingen (San Diego, California, United States). Hema 3 stain for white
blood cell differential counts was purchased from Fisher Scientific
(Swedesboro, New Jersey, United States). Dye reagent concentrate for
protein determination was obtained from Bio-Rad Laboratories.
A2AR-selective agonist CGS21680 and antagonist ZM241385 were
purchased from Tocris (Ellisville, Missouri, United States). A kit for
cAMP enzyme immunoassay was purchased from Amersham Pharma-
cia Biotech (Piscataway, New Jersey, United States). Isoflurane was
obtained from Baxter (Deerfield, Illinois, United States). All other
chemicals were purchased from Sigma Chemicals.
Statistics. Data are represented as individual values. In the graphs,
the horizontal lines give the means of the individual values.
Comparison between independent samples was performed by two-
tailed nonparametric Mann-Whitney test. To test for the strength of
the relationship between two variables, linear regression analysis was
performed and Pearson correlation coefficients calculated. Differ-
ences between survival rates were tested by Chi2 test.
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